AFP has also been demonstrated to be an excellent marker in predicting tumour recurrence during follow-up with one 10 year retrospective study reporting no imaging identifiable relapses from hepatoblastoma without an abnormal elevation of serum AFP levels [24]. The gene discussed is AFP; the disease is hepatoblastoma.